StockData
Corbus Pharmaceuticals Holdings, Inc. logo

Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock

CRBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$2.75−0.26 (-8.80%)

Close on Nov 18, 2026Market cap $53.09MP/E –Yield –

Corbus Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Corbus Pharmaceuticals's market cap was $74.69M on Nov 11, 2026, against $144.65M a year earlier. Over the last 5 years it ranged from $12.47M to $703.50M, with a median of $90.98M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$74.69M-26.8%
2025Dec 31, 2025$102.03M-29.0%
2024Dec 31, 2024$143.72M+437.9%
2023Dec 29, 2023$26.72M+92.1%
2022Dec 30, 2022$13.91M-82.0%
2021Dec 31, 2021$77.11M-25.0%
2020Dec 31, 2020$102.77M-70.9%
2019Dec 31, 2019$353.15M+5.6%
2018Dec 31, 2018$334.30M-6.3%
2017Dec 29, 2017$356.62M-4.1%
2016Dec 30, 2016$371.73M+499.1%
2015Dec 31, 2015$62.05M-19.6%
2014Dec 31, 2014$77.15M–

More Corbus Pharmaceuticals figures

See a number that looks wrong?